Menu

Agenda

Wednesday, November 14

3:00 pm – 6:00 pm AONN+ Certification Exams

Thursday, November 15

7:00 am – 1:00 pm Demystifying the Research Process: Workshop for Patient Navigators, Social Workers, and Administrators (How to publish your navigation QI project demonstrating enhanced patient satisfaction, clinical outcomes, and return on investment)
Pamela Goetz BA, OPN-CG, Danelle Johnston, RN, MSN, ONN-CG, OCN, CBCN, Elaine Sein, RN, BSN, Sharon S. Gentry, RN, MSN, AOCN, CBCN, ONN-CG, Tricia Strusowski, MS, RN, Barbara R. McHale, RN, BS, OCN, CBCN, ONN-CG, Elizabeth Glidden, MPH, OPN-CG, Kristin Lee Siyahian, Kym Dean, RN, NBSN, OCN, Natalie Fellers, BS, Linda Bily, MA, CSA, OPN-CG, Lauren Malloy, MSW, LMSW, OPN-CG, Nicole Centers, RN, NSM, OCN, CBCN, CN-BN, Claudia T. Miller, BSN, RN, OCN, ONN-CG,

Read Overview

Demystifying the Research Process: Workshop for Patient Navigators, Social Workers, and Administrators (How to publish your navigation QI project demonstrating enhanced patient satisfaction, clinical outcomes, and return on investment)
Pamela Goetz BA, OPN-CG, Danelle Johnston, RN, MSN, ONN-CG, OCN, CBCN, Elaine Sein, RN, BSN, Sharon S. Gentry, RN, MSN, AOCN, CBCN, ONN-CG, Tricia Strusowski, MS, RN, Barbara R. McHale, RN, BS, OCN, CBCN, ONN-CG, Elizabeth Glidden, MPH, OPN-CG, Kristin Lee Siyahian, Kym Dean, RN, NBSN, OCN, Natalie Fellers, BS, Linda Bily, MA, CSA, OPN-CG, Lauren Malloy, MSW, LMSW, OPN-CG, Nicole Centers, RN, NSM, OCN, CBCN, CN-BN, Claudia T. Miller, BSN, RN, OCN, ONN-CG,

Description:

AQUIRE, the AONN+ committee that provides education and support to members in the area of quality improvement (QI) and research, is offering this 6-hour preconference program that will include didactic presentations with hands-on exercises and small-group mentoring. Our goal is that you will come away with knowledge about how to conduct and publish your navigation QI projects and research and with concrete next steps to implement your plans when you leave the conference. We will help demystify the research process by taking the work you are already doing to create a structure and plan for demonstrating your successes.

Objectives
Upon completion of the session, participants will be able to:
  • Define the 4 steps in the PDSA process
  • Identify the 3 categories of metrics – business performance (return on investment), clinical outcomes, and patient experience – and how to choose a metric based on the audience (ie, funding source or hospital-identified priority)
  • Describe the importance of including baseline data to strengthen a study and identify the key components of an abstract
  • Recognize how the cancer registry provides data to the Cancer Committee for the Commission on Cancer, National Accreditation Program for Breast Centers (NAPBC) accreditation using data points, and identify ways to utilize this service for their QI projects
  • Formulate strategies to disseminate key findings with stakeholders
  • Apply information presented through interactive activities and compose next steps for clarifying study topic, goals, and methods for their abstract
8:00 am – 11:00 am AONN+ Certification Exams
8:00 am – 12:00 pm Navigation Executive Leadership Preconference: Implementing and Demonstrating Value in an Oncology Navigation Program by Sarah Cannon Leadership
Moderated by Crystal Dugger, MBA, RN, BSN, Assistant Vice President of Clinical Operations
Michelle Rowe, RN, BSHCA, Megan Fletcher, Master of Education in Leadership and Organizational Performance, Rachelle Goerke, MSN, BSN, OCN, Emily Gentry, RN, BSN, OCN, Crystal Dugger, MBA, RN, BSN, Lindsey Reed, BSN, RN, PCN, ONN-CG, Kendra Barber, MHA, RN, OCN, Nicole Centers, RN, NSM, OCN, CBCN, CN-BN, Angie Taylor, Gabrielle Hannafan, Amanda K. Belcher, Richard J. Geer, MD, FACS
 
Navigation Scope: The Do’s and Don’ts Learned
Emily Gentry and Lindsey Reed

Read Overview

Navigation Scope: The Do’s and Don’ts Learned
Emily Gentry and Lindsey Reed

Description:

Whether you are new to navigation or a seasoned veteran, everyone can benefit from a discussion around scope creep and role clarity. Learn from 2 leading directors on how they tackled this topic head- on to ensure that they were promoting compassion satisfaction and work–life balance.

Objectives
Upon completion of the workshop, participants will be able to:
  • Understand and define compassion satisfaction
  • Identify 2 ways to promote wellness in the area of compassion satisfaction
  • Discuss how to define and communicate the role of a navigator with key stakeholders at an organization

Telling Your Story Through Numbers
Kendra Barber and Rachelle Goerke

Read Overview

Telling Your Story Through Numbers
Kendra Barber and Rachelle Goerke

Description:

Help your business plan take flight with the step-by-step guide to building and achieving a successful business proposal and sharing your program’s story.

Objectives
Upon completion of the workshop, participants will be able to:
  • Recognize how to demonstrate the value in your role
  • Discuss how to communicate to key stakeholders how to measure the effectiveness of a navigation program
 
Crafting a Web of Influence
Michelle Rowe and Megan Fletcher

Read Overview

Crafting a Web of Influence
Michelle Rowe and Megan Fletcher

Description:

Successful navigators and leaders must be able to influence. Learn how to network your way to achieving your business goals and ensure you are communicating effectively with key stakeholders.

Objectives
Upon completion of the workshop, participants will be able to:
  • Describe the importance of collaborative relationships
  • Identify potential key relationships in your organization
  • Develop a plan for effective communication

Healthcare Executive Training 101 Panel Discussion moderated by Crystal Dugger

Read Overview

Healthcare Executive Training 101 Panel Discussion moderated by Crystal Dugger

Description:

Learn how to take your program and career to the next level with insights and training from top healthcare leaders from a leading national navigation program.

Objectives
Upon completion of the workshop, participants will be able to:
  • Discuss executive skills needed to advance their career
  • Create a plan on how to obtain the skills identified
  • Explain how these skills will enable success and advancement
8:00 am – 12:00 pm Coaching to Patient Engagement/Activation Workshop
Dawn E. Wiatrek, PhD, Nicole Erb, BA, Shelby Roberts, MPH, Monica Rodriguez, BA, Melissa Hutchison, BA, Latangya Clinton, LMSW, Master of Social Work, Donna Rankin, Nicole Killion, Master in Public Administration, Silvano Gonzalez, Felicia Montgomery, MA

Read Overview

Coaching to Patient Engagement/Activation Workshop
Dawn E. Wiatrek, PhD, Nicole Erb, BA, Shelby Roberts, MPH, Monica Rodriguez, BA, Melissa Hutchison, BA, Latangya Clinton, LMSW, Master of Social Work, Donna Rankin, Nicole Killion, Master in Public Administration, Silvano Gonzalez, Felicia Montgomery, MA

Description:

The purpose of this session is to conduct an educational development workshop on the American Cancer Society Coaching to Patient Engagement/Activation curriculum for clinical and patient navigators.

Objectives
Upon completion of the workshop, participants will be able to:
  • Describe the importance of patient activation/engagement and self-management, and problem- solving/coaching for cancer patients in overcoming/managing barriers to treatment adherence/completion
  • Demonstrate patient-centered communication skills based on a patient’s activation level to assess patient needs
  • Apply patient-centered communication skills and problem-solving/coaching based on a patient’s activation level to increase patient activation/engagement and self-management and develop tailored patient action plans
1:00 pm – 1:15 pm Opening Remarks and Overview
Tricia Strusowski, MS, RN
1:15 pm – 2:30 pm AONN+ Lunch
Exploring Differences in Disease and Care for African Americans Living with Multiple Myeloma
Maggie Kavanaugh
Presentation by Celgene
2:30 pm – 3:15 pm General Session 1: AJCC Staging: Exploring New Changes through Case Studies
Lavinia Dobrea, MS, RN, OCN, Sharon S. Gentry, RN, MSN, AOCN, CBCN, ONN-CG

Read Overview

General Session 1: AJCC Staging: Exploring New Changes through Case Studies
Lavinia Dobrea, MS, RN, OCN, Sharon S. Gentry, RN, MSN, AOCN, CBCN, ONN-CG

Description:

This session will discuss some of the important changes to the 8th edition of the American Joint Committee on Cancer (AJCC) staging that are new in 2018 by looking at 2 case studies, one for breast cancer and one for head and neck.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the intent and purpose of AJCC staging
  • Discuss the oncology nurse navigator’s role in providing education and support to patients during staging
  • Understand how the revised TNM staging system for breast cancer now incorporates tumor grade, hormone receptor expression, HER2 status, and gene-expression panels into a new prognostic stage classification
  • Explain the significant changes in head and neck staging related to HPV status
3:15 pm – 4:00 pm General Session 2: Critical Discussion: Management of Disparate Populations within the Radiation Oncology Setting
Daniel Lenard, BS, RT (R)(T)(ARRT), Jason Coker, PhD

Read Overview

General Session 2: Critical Discussion: Management of Disparate Populations within the Radiation Oncology Setting
Daniel Lenard, BS, RT (R)(T)(ARRT), Jason Coker, PhD

Description:

This session will discuss the current landscape of the underserved and underinsured cancer population in the radiation oncology setting. The audience will be informed about the current barriers and challenges working with disparate populations and how to develop sustainable processes to deliver high-quality care to these patients. There will be an opportunity to have open dialogue with the faculty presenters to discuss current system challenges and opportunities for improvement.

Objectives
Upon completion of the session, participants will be able to:
  • Define the role of the oncology navigator working with the multidisciplinary team to deliver the quality care to disparate cancer populations within the radiation oncology setting
  • Discuss the challenges faced by disparate populations accessing and receiving radiation therapy
  • Describe the role of the oncology administrator to develop and support the program’s outreach and services for the underserved populations
   
4:15 pm – 5:00 pm General Session 3: Essential Conversations on Navigating through the Challenges in Oral Oncolytics
Kristina Rua, BSN, RN, ONN-CG, Clara Lambert, BBA, OPN-CG, Rowena Schwartz, PharmD, BCOP

Read Overview

General Session 3: Essential Conversations on Navigating through the Challenges in Oral Oncolytics
Kristina Rua, BSN, RN, ONN-CG, Clara Lambert, BBA, OPN-CG, Rowena Schwartz, PharmD, BCOP

Description:

This session will discuss the challenges involved in the navigation process when dealing with oral oncolytics. Barriers to care, tracking methods, and educational opportunities will be identified and explained. Facilitated discussion will focus on how to implement improvement for institution/practice processes for oral oncolytics implementation and management.

Objectives
Upon completion of the session, participants will be able to:
  • Identify and apply oral oncolytic tracking mechanisms
  • Discuss methods to educate patients on the importance of adherence, symptom management, and evaluate patient understanding
  • Analyze and explain pharmacy benefits relating to oral oncolytics
  • Develop and assist patients with a funding plan to remove financial barriers
5:00 pm – 5:45 pm General Session 4: Continuing the Conversation on Clinical Trials: The Critical Role That Navigators Play in Providing Education and Access to Patients
Lucy J. Gansauer, MSN, RN, ONC, CCRP, Lavinia Dobrea, MS, RN, OCN, Karen Winkfield, MD, PhD

Read Overview

General Session 4: Continuing the Conversation on Clinical Trials: The Critical Role That Navigators Play in Providing Education and Access to Patients
Lucy J. Gansauer, MSN, RN, ONC, CCRP, Lavinia Dobrea, MS, RN, OCN, Karen Winkfield, MD, PhD

Description:

This session will address the role of both clinical and patient navigators in the clinical trials space for oncology patient management and care coordination; discuss the tools and resources available to navigators to appropriately identify trials for patients; and facilitate discussion on how to increase clinical trials outreach and enrollment in disparate populations.

Objectives
Upon completion of the session, participants will be able to:
  • Identify the roles for the patient and clinical navigator in increasing awareness and access to clinical trials
  • Compile clinical trial options for patients with cancer locally and through ClinicalTrials.gov and other resources
  • Summarize best practices in clinical trials education and elimination of barriers to underserved and minority cancer patients
5:45 pm – 7:00 pm AONN+ Dinner
A Treatment Option for Patients with HR+/HER2- Advanced or Metastatic Breast Cancer
Rodney J. Hunter, PharmD, BCOP
Presentation by Lilly Oncology†
7:00 pm – 9:00 pm Lillie’s Story: A Family Affair
Lillie D. Shockney, RN, BS, MAS, ONN-CG, Charmayne Dierker

Read Overview

Lillie’s Story: A Family Affair
Lillie D. Shockney, RN, BS, MAS, ONN-CG, Charmayne Dierker

Description:

Spend an evening with Lillie Shockney along with her mother as they share their personal journey with Lillie’s breast cancer diagnosis. Hear how the cancer diagnosis impacted generations of women. Be prepared to be moved, laugh, and cry all at the same time while learning about their family’s cancer experience.

Friday, November 16

7:45 am – 9:00 am AONN+ Breakfast
Identifying appropriate patients for NINLARO® (ixazomib): an oral treatment for patients with multiple myeloma
K. Elizabeth Carter, RN, BSN, OCN
Presentation by Takeda †
9:00 am – 10:00 am General Session 5: Immunotherapy
Moderator: Lillie D. Shockney, RN, BS, MAS, ONN-CG, Carsten Kampe, MD, PhD, Brianne Dart, David Dart, CPA

Read Overview

General Session 5: Immunotherapy
Moderator: Lillie D. Shockney, RN, BS, MAS, ONN-CG, Carsten Kampe, MD, PhD, Brianne Dart, David Dart, CPA

Description:

This session will be an introduction to immunotherapy as a unique cancer treatment that activates cells of the immune system to attack and destroy cancer cells. It will discuss the appropriate selection, administration, and side effects of immunotherapy and will describe checkpoint inhibitors, monoclonal antibody therapy, and combination regimens. Financial implications, coverage, and reimbursement issues will be identified and discussed as well as case studies illustrating the challenges for patients receiving immunotherapy.

Objectives
Upon completion of the session, participants will be able to:
  • Discuss the appropriate selection, administration, and side-effect management of immunotherapy with patients and caregivers
  • Identify financial implications, coverage, and reimbursement issues as discussion points for patients and caregivers
  • Employ and discuss patient education as well as resources that are available to patients and caregivers
10:00 am – 11:00 am General Session 6: NAVmetrics™ the Next Generation
Danelle Johnston, RN, MSN, ONN-CG, OCN, CBCN, Elaine Sein, RN, BSN, Tricia Strusowski, MS, RN

Read Overview

General Session 6: NAVmetrics™ the Next Generation
Danelle Johnston, RN, MSN, ONN-CG, OCN, CBCN, Elaine Sein, RN, BSN, Tricia Strusowski, MS, RN

Description:

The National Metrics Study is a one-of-a-kind study that will validate the AONN+ national evidence-based navigation metrics. The audience will hear the intricate details of the NAVmetricsTM study from the development of the study protocol, evidence-based tools selected, barriers and challenges recognized in collecting metrics, and which navigation metrics were selected.

Objectives
Upon completion of the session, participants will be able to:
  • State the overall National Metrics Study objectives and desired outcomes
  • Explain and define the 10 AONN+ Evidence-Based Metrics that are being collected in the national study
  • Apply performance improvement methodology with implementation of benchmark and outcomes data to demonstrate improved outcomes
  • Discuss to date national study progress, initial outcomes, and next steps
10:00 am – 11:15 am Patient Navigator Track: Merck Grant Outcomes 5a presented by ACS
Dawn E. Wiatrek, PhD, Nicole Erb, BA, Shelby Roberts, MPH

Read Overview

Patient Navigator Track: Merck Grant Outcomes 5a presented by ACS
Dawn E. Wiatrek, PhD, Nicole Erb, BA, Shelby Roberts, MPH

Description:

The Merck Foundation has funded a 4-year grant to support the development and testing of a quality improvement program for American Cancer Society patient navigators. The purpose of this session is to provide an overview of the project design and Care Coordination Navigation Program to Reduce Disparities in Cancer Care pilot program. Preliminary results, lessons learned from the process, outcomes evaluation data and next steps for implementation and dissemination will be shared.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the importance of patient activation/engagement and self-management, and problem- solving/coaching for cancer patients in overcoming/managing barriers to treatment adherence/completion
  • Describe the project design and program components
11:15 am - 12:30 pm Patient Navigator Track: Cultural Competency/Sensitivity 5b presented by ACS
Tawana Thomas-Johnson

Read Overview

Patient Navigator Track: Cultural Competency/Sensitivity 5b presented by ACS
Tawana Thomas-Johnson

Description:

The Merck Foundation has funded a 4-year grant to support the development and testing of a quality improvement program for American Cancer Society patient navigators. The purpose of this session is to provide an overview of the project design and Care Coordination Navigation Program to Reduce Disparities in Cancer Care pilot program. Preliminary results, lessons learned from the process, outcomes evaluation data and next steps for implementation and dissemination will be shared.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the importance of patient activation/engagement and self-management, and problem- solving/coaching for cancer patients in overcoming/managing barriers to treatment adherence/completion
  • Describe the project design and program components
  • Discuss lessons learned and implications for practice
11:15 am – 12:15 pm Breakout Session 1: It’s Raining Men! All about cancer screening, prevention and management strategies, and counseling for men
Frank dela Rama, RN, MS, AOCNS, AGN-BC

Read Overview

Breakout Session 1: It’s Raining Men! All about cancer screening, prevention and management strategies, and counseling for men
Frank dela Rama, RN, MS, AOCNS, AGN-BC

Description:

This session will identify significant issues in men’s health, specific to cancer screening, treatment, as well as survivorship care. Prevention and management strategies for the most common cancer types will be reviewed, including prostate, testicular, and colon. Distinct approaches in counseling the male patient will be discussed.

Objectives
Upon completion of the session, participants will be able to:
  • Describe population-based screening guidelines for the most common cancers affecting men
  • Identify treatment-based side effects and their management, as pertinent to the role of the oncology nurse navigator working with the male patient
  • Discuss optimal counseling strategies for the typical male patient in cancer care
11:15 am – 12:15 pm Breakout Session 1: Head & Neck Cancer: What’s New, What’s Next?
Peg Rummel, RN, MHA, OCN, ONN-CG, Karen Godinez, RD, CSO

Read Overview

Breakout Session 1: Head & Neck Cancer: What’s New, What’s Next?
Peg Rummel, RN, MHA, OCN, ONN-CG, Karen Godinez, RD, CSO

Description:

This session will describe the changing landscape of head and neck cancers (HNC), including the role of HPV status in determining patient management and outcomes. Understanding and managing the long-term side effects of head and neck cancer treatment will be reviewed. The challenges of navigating this population will be discussed, and resources will be identified to help manage patients throughout the continuum of care.

Objectives
Upon completion of the session, participants will be able to:
  • Discuss the changing landscape of head and neck cancers, including the management and treatment of HPV-related head and neck cancers
  • Identify resources to help in the management of head and neck cancer patients throughout the treatment trajectory
  • Describe the long-term toxicities of head and neck cancer treatment and the impact on the patient’s quality of life
11:15 am – 12:15 pm Breakout Session 1: The Evolving Landscape of Pancreatic/GI Cancer
Trish Gambino, MSN, RN

Read Overview

Breakout Session 1: The Evolving Landscape of Pancreatic/GI Cancer
Trish Gambino, MSN, RN

Description:

This session will identify the current treatment and management of pancreatic/gastrointestinal (GI) cancers throughout the cancer continuum. It will describe the key role of patient/clinical navigators in assisting patients to the proper treatment modalities and identifying barriers to care. Resources specific to this disease population will be discussed.

Objectives
Upon completion of the session, participants will be able to:
  • Discuss the role of the clinical/patient navigator in supporting patients throughout the cancer trajectory
  • Identify current and emerging treatments for locally advanced, recurrent and metastatic pancreatic/GI cancers, including targeted therapies and clinical trials
  • List resources specific to the pancreatic/GI population
  • Describe barriers that the clinical/patient navigator has in caring for pancreatic/GI patients
11:15 am – 12:15 pm Breakout Session 1: I Am Woman: GYN Oncology
Penny Daugherty, RN, MS, OCN, ONN-CG, Daniel Lenard, BS, RT (R)(T)(ARRT)

Read Overview

Breakout Session 1: I Am Woman: GYN Oncology
Penny Daugherty, RN, MS, OCN, ONN-CG, Daniel Lenard, BS, RT (R)(T)(ARRT)

Description:

This session will define the various diagnoses classified as gynecologic malignancies and address the discreet nuances of each disease as well as recognition and management of specific side effects associated with individual syndromes. Conventional and targeted therapies will be reviewed as well as a discussion assisting patients in the selection of integrative approaches to care.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the significance of the various diseases that encompass the scope of gynecologic malignancies
  • Define the role of clinical and patient navigators through the cancer care continuum for the gynecologic oncology patient and caregivers
  • State the management, guidance, and care of various side effects associated with gynecologic malignancies and their therapies as well as gain understanding of various integrative modalities
12:30 pm – 1:45 pm AONN+ Lunch
Presentation by Merck
Suzanne McGettigan, MSN, CRNP, AOCN
2:00 pm – 3:00 pm General Session 7: Navigating CAR T-Cell Therapy
Claire White, BSN, RN

Read Overview

General Session 7: Navigating CAR T-Cell Therapy
Claire White, BSN, RN

Description:

This session will discuss the evolution of chimeric antigen receptor (CAR) T-cell therapy, including the production and structure of CAR T-cells, future perspectives and next-generation technology. Understanding and managing side effects of CAR T-cell therapy will be reviewed. Navigating clinical trials and availability of treatment will be discussed with participants.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the structure, mechanism, and administration of CAR T-cells
  • Identify prevention and management of adverse effects associated with CAR T-cell therapy
  • Explain the operational considerations associated with implementing commercially available CAR T-cell products into clinical practice as well as next-generation technology
2:00 pm – 3:00 pm General Session 7A: ACS Patient Navigation Track - Building Collaboration between Clinical and Patient Navigation
Michelle Johnson, LMSW, MSW, Sharon S. Gentry, RN, MSN, AOCN, CBCN, ONN-CG, Elizabeth F. Franklin, LGSW, ACSW, Elizabeth Glidden, MPH, OPN-CG, Sandy Lindsey, BSN, OCN

Read Overview

General Session 7A: ACS Patient Navigation Track - Building Collaboration between Clinical and Patient Navigation
Michelle Johnson, LMSW, MSW, Sharon S. Gentry, RN, MSN, AOCN, CBCN, ONN-CG, Elizabeth F. Franklin, LGSW, ACSW, Elizabeth Glidden, MPH, OPN-CG, Sandy Lindsey, BSN, OCN

Description:

Collaboration in the healthcare setting is delineated by professionals assuming complementary roles and shared responsibility to support patients. This interactive panel will discuss the importance of cross-collaboration of all disciplines of navigators to meet the unique needs of patients and families. The session will describe the role of the patient navigator on the multidisciplinary team, as well as discuss the best practices and challenges in multidisciplinary communication.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the roles of clinical and patient navigators on the multidisciplinary team
  • Discuss best practices and challenges in multidisciplinary communication
  • Discuss the role delineation between nurse, nonclinical (professional), and social work patient navigators
  • Describe examples of cross-collaboration of all disciplines of navigators that best meets the needs of patients and families
3:00 pm – 4:00 pm General Session 7B: ACS Patient Navigation Track - Caring for the Caregiver
Rachel Cannady, BS

Read Overview

General Session 7B: ACS Patient Navigation Track - Caring for the Caregiver
Rachel Cannady, BS

Description:

Caregivers may be partners, family members, or close friends. Most often, they are not trained for the caregiver job. Many times, they are the lifeline of the person with cancer. This session will highlight the unique needs of cancer caregivers, the interventions to support caregivers, and resources available through the American Cancer Society.

Objectives
Upon completion of the session, participants will be able to:
  • The participant will be able to describe the unique needs of family caregivers of cancer survivors
  • The participant will be informed about interventions to support family caregivers of cancer survivors
  • The participant will be able to describe support resources for family caregivers available through the American Cancer Society
3:00 pm – 6:00 pm Exhibit Hall Open
Poster Q&A Session
4:00 pm – 5:00 pm Product Theater 1
NERLYNX® (neratinib) tablets: The Next Step in Early-Stage HER2+ Breast Cancer
Speaker: Victoria Poillucci, ANCP-BC, MSN, RN
Presentation by PUMA
4:00 pm – 5:00 pm Product Theater 2
Addressing the Unmet Need For Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Speaker: Kristi Kay Orbaugh, RN, MSN, RNP, AOCN
Presentation by AstraZeneca
6:00 pm – 7:15 pm AONN+ Dinner
Spotlight on Cancer Morbidities: Febrile Neutropenia and Bone Complications
Blanca Ledezma, MSN, NP
Presentation by Amgen†

7:15 pm – 10:00 pm Poster Presentations followed by Dessert Reception Sponsored by Pfizer Oncology

Saturday, November 17

7:45 am – 9:00 am AONN+ Breakfast
ALUNBRIG® (brigatinib) Information for Advanced Practice Providers and Nurses
Rebekah Tobin, RN, BSN
Presentation by Takeda Oncology†
9:00 am – 10:00 am Keynote Session
“The Urgency of Now”
Presented by Dr. Jill Biden, Ed.D
10:15 am – 11:15 am General Session 8: Supercharge Your Program: Program Navigation Development, Implementation, and Sustainment
Moderator: Lillie Shockney , RN, BS, MAS, ONN-CG
Speakers: Crystal Dugger, MBA, RN, BSN, Katherine Sharpe, MTS, Sloan Maes, MSN, RN,

Read Overview

General Session 8: Supercharge Your Program: Program Navigation Development, Implementation, and Sustainment
Moderator: Lillie Shockney , RN, BS, MAS, ONN-CG
Speakers: Crystal Dugger, MBA, RN, BSN, Katherine Sharpe, MTS, Sloan Maes, MSN, RN,

Description:

A panel of oncology administrative leaders to address the current oncology healthcare landscape and discuss the barriers and challenges faced in program navigation development, implementation, and sustainment. The audience will have an opportunity to engage and address questions with the panel of experts.

Objectives
Upon completion of the session, participants will be able to:
  • Discuss the foundational steps in design and implementation for a sustainable navigation program
  • Define the return on investment measures to demonstrate navigation’s program value and sustainability
  • Describe the process to secure a physician champion and executive leadership buy-in for the attainment and sustainment of a successful navigation program
  • Discuss the barriers and challenges with administrative engagement in navigation program sustainment and growth
11:15 am – 12:15 pm Breakout Session 2: Advancing Patient Care through Prehab and Rehab
Ashley Lightner, PT, DPT, CLT, ReVital Cancer Rehab Certified, Stacye Mayo, MOT, OT/L, CLT-LANA

Read Overview

Breakout Session 2: Advancing Patient Care through Prehab and Rehab
Ashley Lightner, PT, DPT, CLT, ReVital Cancer Rehab Certified, Stacye Mayo, MOT, OT/L, CLT-LANA

Description:

This session will discuss and define the concept of Cancer Prehabilitation as a process on the cancer continuum occurring at the time of diagnosis. Employing pertinent assessments, which establish baseline physical and psychosocial levels with a focus on improving patient outcomes, both physically and functionally, will be shared. Case studies will be presented that will illustrate patient quality of life as well as institutional return on investment.

Objectives
Upon completion of the session, participants will be able to:
  • State their role as navigators in the implementation of assessments which will provide a valid baseline measurement of patients. Establish individual patient needs to be met to insure opportunities for improved quality of life going forward into and through treatment.
  • Identify patient barriers to improve patient quality of life to evaluate successful strategies to assist with best individual outcomes for patients and their caregivers
  • Discuss prehabilitation case studies, which demonstrate institutional return on investment as well as positive outcomes for patients
Breakout Session 2: Silent Suffering: Compassion Fatigue & Burnout
Emily Gentry, RN, BSN, OCN

Read Overview

Breakout Session 2: Silent Suffering: Compassion Fatigue & Burnout
Emily Gentry, RN, BSN, OCN

Description:

This session will discuss the implications compassion fatigue and burnout have on healthcare professionals if unaddressed, as well as identifying the expected gains by improving one’s self-resilience and how to incorporate prevention strategies into a self-care regimen will be explored.

Objectives
Upon completion of the session, participants will be able to:
  • Define the difference between compassion fatigue and burnout
  • Identify the characteristics of compassion fatigue and burnout
  • Discuss the importance of resilience and self-care
  • Identify prevention strategies for self-care
 
Breakout Session 2: Navigating Cancer Nutrition
Karen Godinez, RD, CSO

Read Overview

Breakout Session 2: Navigating Cancer Nutrition
Karen Godinez, RD, CSO

Description:

This session will discuss the impact of nutrition at cancer diagnosis, during treatment, and into survivorship. Understanding and managing side effects of treatment, such as malnutrition, anorexia, cachexia, and weight gain, will be reviewed. Providing support and navigation through nutrition therapy to help cancer patients keep a healthy body weight, maintain strength, keep body tissue healthy, and decrease side effects both during and after treatment will be identified.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the side effects of cancer and cancer treatment that affect nutrition, including chemotherapy, hormone therapy, radiation therapy, surgery, and immunotherapy
  • Discuss treatment and supportive care needs to the cancer patient experiencing malnutrition, anorexia, cachexia, and weight gain secondary to cancer and cancer therapy
  • State the nutritional needs of cancer survivors
  • Identify the role of the dietitian in navigating cancer patients through the cancer continuum

Breakout Session 2: Acuity: The 36th Metric
Beth High, MSN, RN, OCN, CBCN, CN-BN, Diane Baldwin, RN, OCN, CBCN

Read Overview

Breakout Session 2: Acuity: The 36th Metric
Beth High, MSN, RN, OCN, CBCN, CN-BN, Diane Baldwin, RN, OCN, CBCN

Description:

The concept of patient acuity is being developed into new levels to address measurement of navigation caseload and productivity. In this breakout session, you will learn novel ways to apply those concepts and transform the way you think about navigation workloads and navigation-driven patient outcomes.

Objectives
Upon completion of the session, participants will be able to:
  • Discuss the concept of navigation-specific patient acuity
  • Demonstrate novel ways to apply acuity to navigation
    • Case Study: Balancing workload with acuity using the “Rule of 400”
    • Case Study: Showcase acuity as a driver of navigation activity and as a patient-outcome metric
  • Define the AONN+ Navigation Acuity Tool Initiative
12:30 pm – 1:45 pm AONN+ Lunch†
Clinical Management of Advanced RCC Patients on CABOMETYX®
Zita Lim, PA
Presentation by Exelixis
2:00 pm – 5:00 pm Exhibit Hall Open
2:00 pm – 3:00 pm Product Theater 3
Tailoring Treatment for Early-Stage, ER-Positive, HER2-Negative Breast Cancer in the Era of Precision Medicine: A Nursing Perspective
Mary A. Van Cleave, BSN, RN, OCN, Cecilia Hammond, MSN, RN
Presentation by Genomic Health OncotypeDx
2:00 pm – 3:00 pm Product Theater 4
SIR-Spheres® Y-90 resin microspheres for the treatment of inoperable metastatic colorectal liver tumors
Islam Shahin, MD, Lakshmi Priya Kannan, MD, Suzanne Lindley, Carolyn Murrah
Presentation by Sirtex

4:00 pm – 5:00 pm Product Theater 5
“The Life of Jane Kren” A Breast Cancer Journey introducing NAVIFY Tumor Board Platform by ROCHE DIAGNOSTIC INFORMATION SOLUTIONS
Cindy Barnard, RN, BSN, OCN, CBCN, Frani Gerst - Associate Marketing Manager
Presentation by Roche Diagnostics
5:00 pm – 6:00 pm Leadership Live: AONN+ Town Hall
AONN+ Leadership Council
6:00 pm - 7:15 pm AONN+ Dinner
Understanding Early Molecular Diagnosis & Navigating Individualized Treatment for EGFR+ mNSCLC
Tarek M. Mekhail, MD, Bassam S. Ghabach, MD
Presentation by Boehringer Ingelheim†
7:30 pm – 10:30 pm AONN+ Award Event

Sunday, November 18

7:30 am – 9:00 am Breakfast in the Exhibit Hall†
9:00 am – 10:00 am General Session 9: Genetics, Genomics, and You: A Primer for Oncology Clinical & Patient Navigators
Moderator: Jen Klemp, PhD, MPH, MA
Speakers: Frank dela Rama, RN, MS, AOCNS, AGN-BC, Theodora S. Ross, MD, PhD

Read Overview

General Session 9: Genetics, Genomics, and You: A Primer for Oncology Clinical & Patient Navigators
Moderator: Jen Klemp, PhD, MPH, MA
Speakers: Frank dela Rama, RN, MS, AOCNS, AGN-BC, Theodora S. Ross, MD, PhD

Description:

This session will describe current and emerging technologies in genetics and genomics as applied to cancer prevention, treatment, and management. Basic genetic concepts, pertinent to oncology nurse and patient navigators, will be reviewed. Case studies and family pedigrees will be discussed, to best illustrate the role of the oncology navigator specific to cancer genetics and genomics.

Objectives
Upon completion of the session, participants will be able to:
  • Identify basic concepts and principles in cancer genetics, specific to the oncology navigator role
  • Describe at least 2 nursing interventions, focusing on genetics or genomics
  • Identify at least 2 current genetics/genomics technologies used within the cancer care continuum
10:00 am – 11:00 am General Session 10: “What’s Hot and Trending in Oncology Care”
Carey S. Clark, PhD, RN, AHN-BC, RYT, Elizabeth F. Franklin, LGSW, ASCW, Tonya Edwards, MS, MSN, RN, FNP-C

Read Overview

11:00 am – 11:30 am Closing Remarks
Tricia Strusowski, MS, RN
11:30 am – 1:30 pm Hands-On Integrative Therapies

Read Overview

Hands-On Integrative Therapies

Description:

Integrative breakout sessions will allow oncology navigators hands-on exposure to integrative sessions, including pet therapy, aromatherapy, drumming, and Reiki. This educational activity is designed to provide navigators with an overview of integrative modalities and treatments that are beneficial for oncology patients and self-care for caregivers throughout the cancer continuum.

Objectives
Upon completion of the session, participants will be able to:
  • Describe the benefits of pet therapy throughout the cancer continuum for patients and caregivers
  • Identify the effects of drumming on the body and its benefits throughout the cancer continuum for patients and caregivers
  • Recognize the effects of aromatherapy on side effects caused by cancer treatment
  • Describe the effects of Reiki therapy on stress reduction and relaxation during cancer treatment and into survivorship
 
Hands-On Integrative Therapies:
Therapy Dogs
Linda Marler, RN, BSN, CRRN

Hands-On Integrative Therapies:
Aromatherapy
Kaye Reviere, M.Ed, BS

Hands-On Integrative Therapies:
Healing Touch
Denise Yoshihara, MSW, LCSW, OSW-C, Penny Daugherty, RN, MS, OCN, ONN-CG

Hands-On Integrative Therapies:
Art Therapy
Carol Edmonston, BS Physical Therapy

*Agenda is subject to change.

All meals provided by AONN+

Thank you to our Corporate Sponsors and Alliance Partners!

  • National Alliance Partner

    National Alliance Partner

  • National Alliance Partner

    National Alliance Partner

  • National Healthcare SystemAlliance Partner

    National Healthcare System
    Alliance Partner

  • National Healthcare SystemAlliance Partner

    National Healthcare System
    Alliance Partner

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Cornerstone Corporate Sponsor

    Cornerstone Corporate Sponsor

  • Industry Relations Council Alliance Sponsor

    Industry Relations
    Council Alliance Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member